Welcome to Oncternal Therapeutics
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments to treat hematological malignancies and prostate cancer across multiple modalities.
On September 12, 2024, Oncternal announced it was discontinuing its clinical trials and exploring strategic alternatives.